Adverse effects associated with BPC-157 are minimal, with only mild and temporary discomfort reported at the injection site or minor gastrointestinal disturbances in some cases
The treatment works in two coordinated steps
Standard pre-treatment bloodwork includes comprehensive metabolic panel to check kidney and liver function, lipid panel for cholesterol, A1C or fasting glucose for diabetes screening, and thyroid panel
Low levels of glutathione are also associated with chronic exposure to chemical toxins and alcohol, cadmium exposure, smoking, AIDS/HIV, macular degeneration, Parkinsons disease, and other neurodegenerative disorders
Northwest Peptides supplies 5-Amino-1MQ exclusively for lawful laboratory research
Patients with neurological involvement require more intensive initial treatment with injections on alternate days until no further improvement occurs